These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 10640661)
21. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death. Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609 [TBL] [Abstract][Full Text] [Related]
22. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433 [TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468 [TBL] [Abstract][Full Text] [Related]
24. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020 [TBL] [Abstract][Full Text] [Related]
25. Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation. Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B J Drug Target; 2004; 12(8):477-89. PubMed ID: 15621674 [TBL] [Abstract][Full Text] [Related]
26. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370 [TBL] [Abstract][Full Text] [Related]
27. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy. Etrych T; Mrkvan T; Ríhová B; Ulbrich K J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976 [TBL] [Abstract][Full Text] [Related]
28. Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data. Ríhová B; Strohalm J; Prausová J; Kubácková K; Jelínková M; Rozprimová L; Sírová M; Plocová D; Etrych T; Subr V; Mrkvan T; Kovár M; Ulbrich K J Control Release; 2003 Aug; 91(1-2):1-16. PubMed ID: 12932633 [TBL] [Abstract][Full Text] [Related]
29. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates. Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320 [TBL] [Abstract][Full Text] [Related]
30. Preparation and biological evaluation of polymerizable antibody Fab' fragment targeted polymeric drug delivery system. Lu ZR; Shiah JG; Kopecková P; Kopecek J J Control Release; 2001 Jul; 74(1-3):263-8. PubMed ID: 11489505 [TBL] [Abstract][Full Text] [Related]
31. Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin. Studenovsky M; Ulbrich K; Ibrahimova M; Rihova B Eur J Pharm Sci; 2011 Jan; 42(1-2):156-63. PubMed ID: 21075206 [TBL] [Abstract][Full Text] [Related]
32. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. Ríhová B; Etrych T; Pechar M; Jelínková M; Stastný M; Hovorka O; Kovár M; Ulbrich K J Control Release; 2001 Jul; 74(1-3):225-32. PubMed ID: 11489498 [TBL] [Abstract][Full Text] [Related]
33. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors. Etrych T; Strohalm J; Chytil P; Říhová B; Ulbrich K J Drug Target; 2011 Dec; 19(10):874-89. PubMed ID: 21978286 [TBL] [Abstract][Full Text] [Related]
34. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis. Zhou Z; Zhang J; Zhang Y; Ma G; Su Z Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095 [TBL] [Abstract][Full Text] [Related]
35. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release. Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465 [TBL] [Abstract][Full Text] [Related]
36. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
37. Preparation of Fab' from murine IgG2a for thiol reactive conjugation. Fowers KD; Callahan J; Byron P; Kopecek JI J Drug Target; 2001; 9(4):281-94. PubMed ID: 11697031 [TBL] [Abstract][Full Text] [Related]
38. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation. Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189 [TBL] [Abstract][Full Text] [Related]
39. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933 [TBL] [Abstract][Full Text] [Related]
40. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. David A; Kopecková P; Minko T; Rubinstein A; Kopecek J Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]